Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors PR Newswire BOSTON, Jan. 13, 2025 Collaboration...
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire BOSTON, Jan. 9, 2025 BOSTON, Jan. 9, 2025 /PRNewswire/ --Β Ginkgo Bioworks (NYSE: DNA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.64 | 29.3659621802 | 8.99 | 11.7275 | 8.44 | 1160408 | 9.70434861 | CS |
4 | 2.17 | 22.9386892178 | 9.46 | 12.75 | 8.44 | 1234922 | 10.15700841 | CS |
12 | 3.5012 | 43.071548076 | 8.1288 | 12.75 | 6.01 | 1312437 | 9.17875036 | CS |
26 | -0.09 | -0.767918088737 | 11.72 | 16.392 | 5.26 | 8528528 | 11.34676099 | CS |
52 | -37.17 | -76.1680327869 | 48.8 | 64.4 | 5.26 | 25305934 | 26.35985959 | CS |
156 | -190.37 | -94.2425742574 | 202 | 255.2 | 5.26 | 23039074 | 68.75141619 | CS |
260 | -437.97 | -97.4132562278 | 449.6 | 634.56 | 5.26 | 21606975 | 84.278221 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.